HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcomes of Severe PARDS on High-Frequency Oscillatory Ventilation - A Single Centre Experience.

AbstractOBJECTIVE:
To describe experience with high-frequency oscillatory ventilation (HFOV) in children with acute respiratory distress syndrome (ARDS) transitioned from conventional mechanical ventilation (CMV) due to refractory hypoxemia and to assess factors associated with survival and also compare outcomes of patients who were managed with early HFOV (within 24 h of intubation) vs. late HFOV.
METHODS:
This retrospective, observational study was conducted in a tertiary care hospital's pediatric intensive care unit. Thirty-four children with pediatric acute respiratory distress syndrome (PARDS) managed with HFOV were included.
RESULTS:
Of 34 children with PARDS managed with HFOV after failure of conventional ventilation to improve oxygenation, 8 survived. Improvement in the Oxygenation Index (OI) at 48 h of initiation of HFOV along with percent increase in PaO2/FiO2 (P/F ratio) at 24 h of HFOV were predictors of survival. The response to HFOV, based on OI and P/F ratio, between 24 and 48 h of ventilation identified potential survivors. Also, lower positive end-expiratory pressure (PEEP) on CMV and shorter duration of CMV before initiation of HFOV were associated with survival.
CONCLUSIONS:
Survival in pediatric ARDS patients treated with HFOV could be predicted by using trends of OI - with survivors showing a more rapid decline in OI between 24 and 48 h of initiation compared to non-survivors.
AuthorsArpita Chattopadhyay, Samriti Gupta, Jhuma Sankar, Sushil K Kabra, Rakesh Lodha
JournalIndian journal of pediatrics (Indian J Pediatr) Vol. 87 Issue 3 Pg. 185-191 (03 2020) ISSN: 0973-7693 [Electronic] India
PMID31925715 (Publication Type: Journal Article)
Topics
  • Blood Gas Analysis
  • Child
  • Child, Preschool
  • Female
  • High-Frequency Ventilation (methods)
  • Humans
  • Hypoxia (therapy)
  • Infant
  • Male
  • Respiration, Artificial (methods)
  • Respiratory Distress Syndrome (therapy)
  • Retrospective Studies
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: